Effect of SARS CoV2-Neutralizing Monoclonal Antibody on Hospitalization and Mortality in Long-Term Care Facility Residents.

Murillo, Monika; Lomiguen, Christine; Terrell, Mark; King, Ashley; Lin, James; Ferretti, Silvia

Murillo, Monika; Lomiguen, Christine; Terrell, Mark; King, Ashley; Lin, James; Ferretti, Silvia.

Afiliación

Murillo M; 1LECOM Health - Millcreek Community Hospital, Erie, Pennsylvania, USA.
Lomiguen C; 2LECOM Health - Institute for Successful Aging, Erie, Pennsylvania, USA.
Terrell M; 3LECOM Health - Medical Associates of Erie, Erie, Pennsylvania, USA.
King A; 4Lake Erie College of Osteopathic Medicine, Erie, Pennsylvania, USA.
Lin J; 1LECOM Health - Millcreek Community Hospital, Erie, Pennsylvania, USA.
Ferretti S; 4Lake Erie College of Osteopathic Medicine, Erie, Pennsylvania, USA.

Aging Dis ; 13(5): 1523-1531, 2022 Oct 01.

Article en En | MEDLINE | ID: mdl-36186125

Palabras clave

COVID-19; SARS-CoV-2; hospitalization; mortality; neutralizing monoclonal antibod

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 4_TD Problema de salud: 4_covid_19 Tipo de estudio: Etiology_studies Idioma: En Revista: Aging Dis Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google